W571 Pill - yellow capsule/oblong, 13mm
Pill with imprint W571 is Yellow, Capsule/Oblong and has been identified as Risperidone 3 mg. It is supplied by Wockhardt USA.
Risperidone is used in the treatment of Autism; Asperger Syndrome; Schizophrenia; Bipolar Disorder; Schizoaffective Disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Risperidone 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W571
Risperidone
- Imprint
- W571
- Strength
- 3 mg
- Color
- Yellow
- Size
- 13.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wockhardt USA
- National Drug Code (NDC)
- 64679-0571 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
D&C Yellow No. 10,
ferric oxide yellow,
hypromelloses,
lactose monohydrate,
magnesium stearate,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "W571"
More about risperidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (720)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Risperidone drug information
- Risperidone injection
- Risperidone (Intramuscular, Subcutaneous) (Advanced Reading)
- Risperidone Injection (IM)
- Risperidone Injection (Subcutaneous)
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, ... +3 more
Professional resources
- Risperidone monograph
- Risperidone (FDA)
- Risperidone Oral Solution (FDA)
- Risperidone Orally Disintegrating (FDA)
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, Rykindo
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.